Followers | 168 |
Posts | 17828 |
Boards Moderated | 3 |
Alias Born | 11/29/2010 |
Friday, August 18, 2017 7:24:30 PM
BLDV was stuck in mid trips the first 19 days of Q2. Then on 4/20 Alper published his infamous PR announcing a partnership with AMS who --he proclaimed-- was in the "final stage of licensing." People obviously read that to mean that AMS was very close to starting production. That set off a buying binge that topped off at .0057.
Only later did people learn that AMS needed an infusion of $12 million --and many more months after funding was secured-- before any licensing and growing would commence.
In the mean time, a lot of money presumably flowed into AMS. It will be interesting to see how Alper used it.
My "opinion" is as valid as your "hearsay"
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM